Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
12.48
-0.46 (-3.55%)
Nov 3, 2025, 11:15 AM EST - Market open
Nurix Therapeutics Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$26.29
Upside
+110.66%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $28 | Strong Buy | Maintains | $33 → $28 | +124.36% | Oct 27, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $22 → $21 | Buy | Maintains | $22 → $21 | +68.27% | Oct 23, 2025 |
| BTIG | BTIG | Strong Buy Maintains $35 → $27 | Strong Buy | Maintains | $35 → $27 | +116.35% | Oct 23, 2025 |
| Needham | Needham | Strong Buy Maintains $27 → $26 | Strong Buy | Maintains | $27 → $26 | +108.33% | Oct 22, 2025 |
| Mizuho | Mizuho | Buy Initiates $24 | Buy | Initiates | $24 | +92.31% | Oct 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +164.42% | Oct 20, 2025 |
| Needham | Needham | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +116.35% | Oct 20, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +20.19% | Oct 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $33 | Strong Buy | Maintains | $34 → $33 | +164.42% | Oct 14, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $35 → $32 | Buy | Maintains | $35 → $32 | +156.41% | Oct 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $30 → $28 | Buy | Maintains | $30 → $28 | +124.36% | Oct 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $32 → $30 | Buy | Reiterates | $32 → $30 | +140.38% | Jul 31, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $16 | Hold | Maintains | $17 → $16 | +28.21% | Jul 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $34 | Strong Buy | Maintains | $36 → $34 | +172.44% | Jul 14, 2025 |
| UBS | UBS | Strong Buy Maintains $30 → $26 | Strong Buy | Maintains | $30 → $26 | +108.33% | Jul 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $32 → $30 | Buy | Maintains | $32 → $30 | +140.38% | Jul 10, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.